CVS Argues For Denial Of Preliminary Injunction Motion In Trade Secret Suit

Mealey's (November 21, 2018, 11:44 AM EST) -- TAMPA, Fla. — Arguing that a third-party administrator of the U.S. government’s 340B drug pricing program’s motion for preliminary injunction in a trade secret misappropriation lawsuit is “late, unsupported by fact...
To view the full article, register now.